MedTrace Logo

Transcutaneous Bilirubin Levels From Covered Skin

NCT06105879 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-10-30

No results posted yet for this study

Summary

The aim of this study was to evaluate the levels of total serum bilirubin and transcutaneous bilirubin in newborns, measured in both covered and exposed areas, before phototherapy, 24th hour of phototherapy and 8 hours after cessation of phototherapy. The study included term and preterm newborns that required phototherapy between postnatal days 0-28. Total serum bilirubin levels and transcutaneous bilirubin measurements were obtained using the MBJ20-2019 Transcutaneous Handheld Bilirubinometer (Beijing M\&B Electronic Instruments Co. Ltd. China, 2019) from both exposed (sternal) and unexposed (forehead, covered with a radio-opaque patch) areas before, at 24th hours and eight hours after phototherapy.

Conditions

  • Hyperbilirubinemia, Neonatal

Interventions

DEVICE

covered or open skin

transcutaneous mesarument of covered or open skin area

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    lead OTHER

Principal Investigators

  • Dilek Kahvecioglu, Assoc.Prof. · Ankara Training and Research Hospital

  • Dilek Kahvecioglu, Assoc.Prof. · Ankara Training and Research Hospital

  • Dilek Kahvecioglu, Assoc.Prof. · Ankara Training and Research Hospital

Eligibility

Min Age
1 Hour
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-06-01
Completion
2023-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06105879 on ClinicalTrials.gov